News

Dechra acquires Sucromate™ Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C

This acquisition expands Dechra’s equine portfolio in the reproductive category.

Dechra receives approval for Amoxicillin and Clavulanate Potassium Oral Suspension Drops

Approval expands Dechra’s growing companion animal products (CAP) range of anti-infectives.

Dechra Acquires Rompun® (xylazine injection) 100mg/ml and Butorphanol Tartrate Injection 10mg/ml from Elanco™ Animal Health

Acquisition expands Dechra’s equine portfolio into the anesthesia and analgesia category.

Dechra Acquires Exclusive License from Hassinger Biomedical for Equine ProVet APC™

Dechra Veterinary Products is pleased to announce the acquisition of the veterinary marketing and distribution rights to the ProVet APC™ (Autologous Platelet Concentrate) and ProVet BMC™ (Bone Marrow Concentrate) systems from Hassinger Biomedical. These two patented medical devices concentrate platelets or bone marrow in 90 seconds with a processing time of 2.5 minutes from start to finish.

Dechra Veterinary Products Partners with I-MED Pharma

Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with I-MED Pharma, the Canadian leader in dry eye management, for three innovative veterinary hyaluronic acid (HA) ophthalmic products.

Dechra Veterinary Products Announces their Sponsorship of the University of Pennsylvania Veterinary Working Dog Center Residency